Legius syndrome, an Update. Molecular pathology of mutations in SPRED1
- PMID: 24334617
- DOI: 10.2302/kjm.2013-0002-re
Legius syndrome, an Update. Molecular pathology of mutations in SPRED1
Abstract
Multiple café-au-lait macules (CALMs) are the hallmark of Von Recklinghausen disease, or neurofibromatosis type 1 (NF1). In 2007 we reported that some individuals with multiple CALMs have a heterozygous mutation in the SPRED1 gene and have NF1-like syndrome, or Legius syndrome. Individuals with Legius syndrome have multiple CALMs with or without freckling, but they do not show the typical NF1-associated tumors such as neurofibromas or optic pathway gliomas. NF1-associated bone abnormalities and Lisch nodules are also not reported in patients with Legius syndrome. Consequently, individuals with Legius syndrome require less intense medical surveillance than those with NF1. The SPRED1 gene was identified in 2001 and codes for a protein that downregulates the RAS-mitogen activated protein kinase (RAS-MAPK) pathway; as does neurofibromin, the protein encoded by the NF1 gene. It is estimated that about 1-4% of individuals with multiple CALMs have a heterozygous SPRED1 mutation. Mutational and clinical data on 209 patients with Legius syndrome are tabulated in an online database (http://www.lovd.nl/SPRED1). Mice with homozygous knockout of the Spred1 gene show learning deficits and decreased synaptic plasticity in hippocampal neurons similar to those seen in Nf1 heterozygous mice, underlining the importance of the RAS-MAPK pathway for learning and memory. Recently, specific binding between neurofibromin and SPRED1 was demonstrated. SPRED1 seems to play an important role in recruiting neurofibromin to the plasma membrane.
Similar articles
-
Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.J Biol Chem. 2016 Feb 12;291(7):3124-34. doi: 10.1074/jbc.M115.703710. Epub 2015 Dec 3. J Biol Chem. 2016. PMID: 26635368 Free PMC article.
-
Review and update of SPRED1 mutations causing Legius syndrome.Hum Mutat. 2012 Nov;33(11):1538-46. doi: 10.1002/humu.22152. Epub 2012 Aug 1. Hum Mutat. 2012. PMID: 22753041 Review.
-
A shared molecular mechanism underlies the human rasopathies Legius syndrome and Neurofibromatosis-1.Genes Dev. 2012 Jul 1;26(13):1421-6. doi: 10.1101/gad.190876.112. Genes Dev. 2012. PMID: 22751498 Free PMC article.
-
Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.J Mol Biol. 2019 Sep 6;431(19):3889-3899. doi: 10.1016/j.jmb.2019.07.038. Epub 2019 Aug 8. J Mol Biol. 2019. PMID: 31401120
-
Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease.Dev Period Med. 2014 Jul-Sep;18(3):297-306. Dev Period Med. 2014. PMID: 25182393 Review.
Cited by
-
Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).Mol Med Rep. 2016 Nov;14(5):4023-4029. doi: 10.3892/mmr.2016.5760. Epub 2016 Sep 22. Mol Med Rep. 2016. PMID: 27666661 Free PMC article. Review.
-
SOCS, SPRED, and NR4a: Negative regulators of cytokine signaling and transcription in immune tolerance.Proc Jpn Acad Ser B Phys Biol Sci. 2021;97(6):277-291. doi: 10.2183/pjab.97.016. Proc Jpn Acad Ser B Phys Biol Sci. 2021. PMID: 34121041 Free PMC article.
-
126 novel mutations in Italian patients with neurofibromatosis type 1.Mol Genet Genomic Med. 2015 Jul 7;3(6):513-25. doi: 10.1002/mgg3.161. eCollection 2015 Nov. Mol Genet Genomic Med. 2015. PMID: 26740943 Free PMC article.
-
Structural Insights into the SPRED1-Neurofibromin-KRAS Complex and Disruption of SPRED1-Neurofibromin Interaction by Oncogenic EGFR.Cell Rep. 2020 Jul 21;32(3):107909. doi: 10.1016/j.celrep.2020.107909. Cell Rep. 2020. PMID: 32697994 Free PMC article.
-
Insights into the Pathogenesis of NF1-Associated Neoplasms.JID Innov. 2021 Sep;1(3):100044. doi: 10.1016/j.xjidi.2021.100044. Epub 2021 Aug 20. JID Innov. 2021. PMID: 34604833 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous